| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 16.896 | 7.902 | 3.411 | 4.629 | 2.596 | 1.516 | 9.790 |
| Total Income - EUR | 0 | 0 | 0 | 16.896 | 7.902 | 3.411 | 4.629 | 2.596 | 1.516 | 9.790 |
| Total Expenses - EUR | 0 | 0 | 0 | 4.623 | 1.465 | 1.252 | 380 | 480 | 417 | 3.559 |
| Gross Profit/Loss - EUR | 0 | 0 | 0 | 12.273 | 6.437 | 2.159 | 4.249 | 2.115 | 1.100 | 6.232 |
| Net Profit/Loss - EUR | 0 | 0 | 0 | 11.766 | 6.200 | 2.057 | 4.113 | 2.037 | 933 | 5.334 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Novosapiens Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 2.119 | 2.098 | 2.062 | 2.024 | 1.985 | 1.948 | 1.904 | 1.910 | 1.905 | 0 |
| Current Assets | 5.546 | 5.489 | 5.397 | 17.573 | 23.166 | 24.825 | 28.375 | 30.877 | 31.660 | 8.487 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 292 | 289 | 285 | 1.246 | 1.222 | 5.308 | 17.602 | 22.523 | 23.425 | 1.349 |
| Cash | 5.254 | 5.200 | 5.112 | 16.326 | 21.944 | 19.518 | 10.773 | 8.354 | 8.235 | 7.139 |
| Shareholders Funds | 7.489 | 7.412 | 7.287 | 18.919 | 24.753 | 26.340 | 29.869 | 31.999 | 32.835 | 5.385 |
| Social Capital | 47 | 47 | 46 | 45 | 44 | 44 | 43 | 43 | 43 | 42 |
| Debts | 177 | 175 | 172 | 678 | 398 | 433 | 410 | 788 | 730 | 3.103 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "5911 - 5911" | |||||||||
| CAEN Financial Year |
5911
|
|||||||||
Comments - Novosapiens Srl